Key Highlights

  • Amdocs (NASDAQ:DOX) changed hands at USD 44.61 on November 4, 2026, sliding 28.55% intraday. The move came after its November 3, 2026 release covering fiscal 2026 numbers and forward guidance.
  • Guidance points to fiscal 2027 reported Revenue falling 14.3% to 17.9%, with non-GAAP diluted EPS dropping 26% to 30% from USD 7.41 in fiscal 2026.
  • Amdocs and its top customer each claim the other committed a material breach, and the outlook assumes either side could terminate, with arbitration on the table.
  • Twelve-month Backlog stood at USD 3.50 billion, about USD 370 million lower sequentially, and guidance for the first fiscal 2027 quarter sits at USD 955 million to USD 995 million.

Session Move (down USD 17.83, 28.55%)

Shares of Amdocs (NASDAQ:DOX) were quoted at USD 44.61 intraday on November 4, 2026, off 28.55%. Back-calculating gives a prior close near USD 62.44, implying a USD 17.83 decline (calculated). Pre-market trading had the stock about 40% lower, and it recovered some ground after the open, though it still sits well beneath the earlier close. The catalyst was the November 3, 2026 release for the fiscal fourth quarter and full year 2026, which combined a respectable quarter with a markedly weaker view for fiscal 2027.

Guidance Details and the Customer Dispute

The company release, furnished on Form 6-K, shows fiscal 2026 revenue of USD 4,697 million, a 3.6% increase, and non-GAAP diluted EPS of USD 7.41, up 6.0%. Fourth-quarter revenue reached USD 1,194 million, up 3.8%, with non-GAAP diluted EPS of USD 1.98. For fiscal 2027, reported revenue is expected to shrink between 17.9% and 14.3%, or between 11% and 7% on a pro forma constant currency basis. GAAP diluted EPS is expected to decline 17% to 25%. Free Cash Flow should land between USD 440 million and USD 500 million. The release notes that each side has sent notices alleging material breach, that termination or monetary claims are possible, and that the guidance assumes either party could terminate.

Why the Reaction Was So Sharp

Backlog refers to contracted work that has yet to be recognized as revenue, and Amdocs reported a twelve-month backlog of USD 3.50 billion, roughly 9.6% lower year over year on an adjusted basis. If one client carries enough weight to swing guidance by double-digit figures, a conflict turns an ordinary renewal into all-or-nothing exposure: arbitration could cut revenue, add legal costs and force restructuring, whereas a deal to resolve matters could tighten the outlook. Margin pressure adds to this because delivery costs that are largely fixed weigh more heavily when sales shrink, so profit drops faster than revenue. The release does not disclose how much revenue the customer represents, so any outside figure for that exposure is an educated guess. Lower profit also leaves less money for Investment and deals, and management has to weigh that against legal spending.

Where Things Stand

Amdocs (NASDAQ:DOX) is down 28.55% intraday on November 4, 2026 because its fiscal 2027 outlook implies a steep revenue drop tied to a contract fight with its largest customer, despite a solid fiscal 2026. Investors are pricing in the possibility of termination and arbitration. Watch for further filings on the dispute, the first quarter fiscal 2027 report with revenue guided to USD 955 million to USD 995 million, and revisions to analyst estimates. Intraday moves can change before the close, and the roughly 40% pre-market loss already showed how jumpy the reaction has been.